June 28, 2018 – The American Food and Drug Administration (FDA), a couple of week ago, approved Erenumab-Aooe (Aimovig) for the preventive treatment of migraine in adults. The treatment is given by once-monthly self-injections. Erenumab-Aooe (Aimovig) is the first FDA-approved …

Erenumab-Aooe (Aimovig): Novel preventive treatment for migraine approved Read more »